Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2006-11-29 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: L'ARGENTIERE-LA-BESSEE (05120), Hautes-Alpes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE L'ARGENTIERE LA BESSEE : revenue, balance sheet and financial ratios
PHARMACIE DE L'ARGENTIERE LA BESSEE is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in L'ARGENTIERE-LA-BESSEE (05120),
this company of category PME
shows in 2025 a net income positive of 150 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE L'ARGENTIERE LA BESSEE (SIREN 493046353)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
150 375 €
124 072 €
99 091 €
130 415 €
110 431 €
104 287 €
105 360 €
103 331 €
102 991 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE L'ARGENTIERE LA BESSEE generates positive net income of 150 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 103 k€ -> 150 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
150 375 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 8%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 85%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
8.464%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
85.206%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE L'ARGENTIERE LA BESSEE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
96.682
76.566
58.535
45.198
36.629
23.293
13.98
11.446
8.464
Financial autonomy
47.479
53.17
59.837
64.389
67.671
74.992
80.813
83.342
85.206
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
8.462025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Excellent
In 2025, the debt ratio of PHARMACIE DE L'ARGENTIERE... (8.46) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
85.21%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent+10 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE L'ARGENTIERE... (85.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 266.12. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
266.115
Liquidity indicators evolution PHARMACIE DE L'ARGENTIERE LA BESSEE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
220.696
236.667
260.96
196.786
195.734
188.107
161.704
276.753
266.115
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
266.122025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent+38 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE L'ARGENTIERE... (266.12) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE L'ARGENTIERE LA BESSEE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
Customer payment term (days)
99
102
61
81
100
138
0
0
0
Supplier payment term (days)
182
430
357
410
469
410
0
0
0
Positioning of PHARMACIE DE L'ARGENTIERE LA BESSEE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE L'ARGENTIERE LA BESSEE is estimated at
2 388 724 €
(range 1 620 999€ - 3 748 238€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1620k€2388k€3748k€
2 388 724 €Range: 1 620 999€ - 3 748 238€
NAF 5 année 2025
Valuation method used
Net Income Multiple
150 375 €
×
15.9x
=2 388 725 €
Range: 1 621 000€ - 3 748 238€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE L'ARGENTIERE LA BESSEE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE L'ARGENTIERE LA BESSEE
What is the revenue of PHARMACIE DE L'ARGENTIERE LA BESSEE ?
The revenue of PHARMACIE DE L'ARGENTIERE LA BESSEE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE L'ARGENTIERE LA BESSEE profitable?
Yes, PHARMACIE DE L'ARGENTIERE LA BESSEE generated a net profit of 150 k€ in 2025.
Where is the headquarters of PHARMACIE DE L'ARGENTIERE LA BESSEE ?
The headquarters of PHARMACIE DE L'ARGENTIERE LA BESSEE is located in L'ARGENTIERE-LA-BESSEE (05120), in the department Hautes-Alpes.
Where to find the tax return of PHARMACIE DE L'ARGENTIERE LA BESSEE ?
The tax return of PHARMACIE DE L'ARGENTIERE LA BESSEE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE L'ARGENTIERE LA BESSEE operate?
PHARMACIE DE L'ARGENTIERE LA BESSEE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart